Technology Analysis

Technology Matrix

Comprehensive capability mapping across human simulation technologies

Organ Coverage

Organ Model Coverage by Company

Which companies offer models for specific organs

Company Liver Kidney Lung Gut Brain/BBB Heart Skin Tumor
Emulate ● ● ● ● ● ○ ○ ●
CN Bio ● ● ○ ● ○ ○ ○ ○
Mimetas ● ● ○ ● ● ○ ○ ●
InSphero ● ○ ○ ○ ○ ● ○ ●
MatTek ○ ○ ● ● ○ ○ ● ○
AxoSim ○ ○ ○ ○ ● ○ ○ ○
AlveoliX ○ ○ ● ○ ○ ○ ○ ○
● Primary Focus ● Available ○ Not Available
Applications

Application Capabilities

Key applications supported by each technology approach

DILI/Hepatotoxicity

Drug-induced liver injury prediction and hepatotoxicity screening

Leaders: Emulate (FDA ISTAND), CN Bio, InSphero

ADME Studies

Absorption, distribution, metabolism, excretion characterization

Leaders: CN Bio, Emulate, TissUse

BBB Penetration

Blood-brain barrier permeability for CNS drug candidates

Leaders: Emulate, Mimetas, SynVivo

Nephrotoxicity

Kidney toxicity assessment and renal drug clearance

Leaders: Mimetas, Nortis, Emulate

Oncology/Tumor

Patient-derived tumor models and immuno-oncology

Leaders: Crown Bioscience, Mimetas, InSphero

Respiratory

Lung models for inhalation and respiratory disease

Leaders: Emulate, AlveoliX, MatTek
Technology Approaches

Platform Technology Breakdown

Flow & Perfusion Systems

Pneumatic

Emulate - Mechanical stretch mimics breathing

Peristaltic

CN Bio - External pumps for controlled flow

Gravity-Driven

Mimetas - No pumps, plate rocker

Pumpless

Hesperos - Self-contained circulation

Cell Source Types

Primary Cells

Freshly isolated human cells with native phenotype

iPSC-Derived

Unlimited supply, patient-specific options

Adult Stem Cell

HUB Organoids approach, tissue-specific

Cell Lines

Reproducible but less physiological

Explore More Analysis

Dive deeper into platform comparisons and market positioning

Platform Comparison Partnership Network All Companies